Statistics
Publications
15
Citations
7.6K
H-Index
14
Active since
2007
Jan Diekmann is an author at BioNTech (Germany) specializing in immunology, oncology, and cancer immunotherapy.
Publications per year
2007–2025
15
15
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Uğur Şahin, Evelyna Derhovanessian, Matthias Miller et al. · Nature · 2017 · 2.5K citations
Medicine, Immunology, Oncology +14
Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
Lena M. Kranz, Mustafa Diken, Heinrich Haas et al. · Nature · 2016 · 1.7K citations
Life Sciences, Immunology, Oncology +17
Mutant MHC class II epitopes drive therapeutic immune responses to cancer
Sebastian Kreiter, Mathias Vormehr, Niels van de Roemer et al. · Nature · 2015 · 1.2K citations · Full text
Life Sciences, Immunology, Oncology +14
Exploiting the Mutanome for Tumor Vaccination
John C. Castle, Sebastian Kreiter, Jan Diekmann et al. · Cancer Research · 2012 · 826 citations · Full text
Medicine, Immunology, Oncology +17
A vaccine targeting mutant IDH1 induces antitumour immunity
Theresa Schumacher, Lukas Bunse, Stefan Pusch et al. · Nature · 2014 · 698 citations
1–5 of 15